50 μg KIO-301

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis PigmentosaNCT06628947KPRXPhase 2Recruiting2027-08Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.